Tania LaGambina
Rosa Biotech accelerates NASH pre-clinical trial in liver disease
Bio-sensing pioneer secures £415,000 from angel investors Funding will accelerate non-alcoholic fatty liver disease (NAFLD / NASH)...
top of page
news and blog
Search
Arne Scott
- Mar 27
- 2 min
Rosa publishes founding research in Nature Communications
We are delighted to publish the founding research behind Rosa and our Pandra platform in Nature Communications. The paper - a...
262 views0 comments
Tania LaGambina
- Oct 18, 2022
- 2 min
Innovate Grant & New Starter
We are pleased to announce that Rosa has been awarded a grant by Innovate UK through its Biomedical Catalyst Feasibility & Primer award....
163 views0 comments
Tania LaGambina
- Sep 12, 2022
- 2 min
Introducing our new CEO: Dr Mark Street-Docherty
We are delighted to announce the appointment of Dr Mark Street-Docherty as Rosa Biotech’s new CEO. Over an exciting past couple of years...
176 views0 comments
Arne Scott
- Jul 21, 2020
- 2 min
New arrivals at Rosa Biotech
Our R&D team is growing! We've welcomed three new faces to Rosa in the last couple of months.
341 views0 comments
Arne Scott
- Nov 1, 2019
- 2 min
Rosa Biotech win award at the Royal Society of Chemistry Emerging Technologies competition
Rosa Biotech has been named one of the most exciting health innovators in Europe after winning a Royal Society of Chemistry (RSC)...
126 views0 comments
Arne Scott
- Oct 31, 2019
- 2 min
Rosa Biotech raise £760,000 to develop groundbreaking biosensing platform
The investment is one of the largest initial sums raised by a University of Bristol spinout company.
376 views0 comments
featured in
bottom of page